Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL): Interim results of a phase II study

Topp, M. S. and Goekbuget, N. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. -A and Reichle, A. and Marks, R. and Klappers, P. and Mergen, N. and Nagorsen, D. and Kufer, P. and Goebeler, M. -E and Einsele, H. and Hoelzer, D. and Bargou, R. (2011) Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL): Interim results of a phase II study. ONKOLOGIE, 34 (Suppl6). p. 16. ISSN 0378-584X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 05 May 2020 06:26
Last Modified: 05 May 2020 06:26
URI: https://pred.uni-regensburg.de/id/eprint/20252

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.